Skip to main content
. 2017 Jul 20;7(7):e015901. doi: 10.1136/bmjopen-2017-015901

Table 4.

Diagnosis and first-line treatment among different respondent groups. X2 test is used for the group comparison. Statistically significant difference (p<0.05) appear in bold

Anaphylaxis diagnosis OR 95% CI p Value Intramuscular adrenalin OR 95% CI p Value Prednisolone OR 95% CI p Value Chloropyramine OR 95% CI p Value
Sex 0.75 (0.36 to 1.57) 0.45 0.71 (0.24 to 2.10) 0.54 1.69 (0.85 to 3.83) 0.14 1.49 (0.70 to 3.15) 0.30
Age 0.97 (0.95 to 1.00) 0.10 0.98 (0.94 to 1.03) 0.42 1.00 (0.98 to 1.04) 0.61 0.97 (0.93 to 0.99) 0.04
Specialty 1.34 (0.77 to 2.35) 0.31 1.30 (0.60 to 2.83) 0.51 1.43 (0.82 to 2.50) 0.20 1.59 (0.85 to 2.97) 0.15
Clinical settings 0.51 (0.30 to 0.86) 0.01 0.74 (0.36 to 1.50) 0.40 1.55 (0.90 to 2.68) 0.11 0.95 (0.52 to 1.73) 0.86
Clinical experience 1.33 (0.59 to 2.99) 0.49 1.39 (0.45 to 4.31) 0.57 0.94 (0.43 to 2.05) 0.88 1.93 (0.81 to 4.61) 0.14
Anaphylaxis diagnosis NA NA 5.65 (2.81 to 11.36) <0.01 0.73 (0.44 to 1.24) 0.24 0.35 (0.19 to 0.67) <0.01